Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
inadvertent administration of the vaccine after a temperature excursion (below freezing); This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: inadvertent administration of the vaccine after a temperature excursion (below freezing)). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 09-JUL-2025 The nurse reported that a patient had been administered a Boostrix vaccine after transport (from nine ante meridiem until nine fifteen ante meridiem) when the temperature was around twenty-seven degrees Fahrenheit and had dropped to negative five point five degrees Fahrenheit which led to, incorrect storage of drug. The reporter mentioned that no vaccination date, vaccine details, or patient demographics details were obtained or specified by the anonymous healthcare provider during the call.